Abiopharma

New Form FWP - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001213900-26-040807 <b>Size:</b> 2 MB

enGene Announces Name Change to enGene Therapeutics Inc.

(50% Neutral) GRAYSCALE ETHEREUM STAKING MINI ETF (ETH) Announces Business Combination

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Changes in Interest of Director and Chief Executive Officer - Dr. Ng Chin Siau

Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Changes in Interest of Substantial Shareholder - Quan Min Holdings Pte. Ltd.

New Form FWP - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001213900-26-040804 <b>Size:</b> 2 MB

(90% Positive) CORBUS PHARMACEUTICALS HOLDINGS, INC. (CRBP) Provides Update on path for CRB-701

Land & Buildings Sends Letter to First Industrial Realty Trust Shareholders Highlighting the Need for Shareholders to Send a Clear Message That Further Change is Required

Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution

BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform

Stratasys Unleashes New Innovations Across its Hardware, Software, and Materials Platform to Power Additive Manufacturing

(50% Neutral) GRAYSCALE ETHEREUM STAKING ETF (ETHE) Announces Business Combination

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001839882-26-019378 <b>Size:</b> 274 KB

Annual Reports and Related Documents::